We know very little about the subjective effects of drugs in females

Rick A Bevins, Sergios Charntikov

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Pharmaceutical companies assessing the nervous system effects of candidate therapeutics often use a behavioral assay in rodents that assesses the drugs subjective (internal stimulus) effects. Variants of this so-called "drug discrimination task" have also been widely used by basic scientist for more than 50 years to study the receptor actions of a host of ligands related to disease states and neuropathologies. Notably, most published research with this task has used male rats or mice. This situation is unfortunate and severely limits the utility of the research, given the well-documented differences between women and men on drug efficacy and safety, as well as known sex differences in the neural and behavioral effects of drugs. In this Viewpoint, we highlight the need for basic researchers, as well as pharmaceutical scientists, to include females in drug discrimination studies in a manner that allows detection and interpretation of potential sex differences.

Original languageEnglish (US)
Pages (from-to)359-361
Number of pages3
JournalACS Chemical Neuroscience
Volume6
Issue number3
DOIs
StatePublished - Mar 18 2015

Fingerprint

Pharmaceutical Preparations
Sex Characteristics
Neurology
Therapeutic Uses
Research
Nervous System
Rats
Rodentia
Assays
Research Personnel
Ligands
Safety
Industry

Keywords

  • Drug discrimination
  • gender differences
  • interoceptive stimuli
  • sex differences

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Cite this

We know very little about the subjective effects of drugs in females. / Bevins, Rick A; Charntikov, Sergios.

In: ACS Chemical Neuroscience, Vol. 6, No. 3, 18.03.2015, p. 359-361.

Research output: Contribution to journalArticle

@article{17c10fba030f4ef7883f955f1adc4165,
title = "We know very little about the subjective effects of drugs in females",
abstract = "Pharmaceutical companies assessing the nervous system effects of candidate therapeutics often use a behavioral assay in rodents that assesses the drugs subjective (internal stimulus) effects. Variants of this so-called {"}drug discrimination task{"} have also been widely used by basic scientist for more than 50 years to study the receptor actions of a host of ligands related to disease states and neuropathologies. Notably, most published research with this task has used male rats or mice. This situation is unfortunate and severely limits the utility of the research, given the well-documented differences between women and men on drug efficacy and safety, as well as known sex differences in the neural and behavioral effects of drugs. In this Viewpoint, we highlight the need for basic researchers, as well as pharmaceutical scientists, to include females in drug discrimination studies in a manner that allows detection and interpretation of potential sex differences.",
keywords = "Drug discrimination, gender differences, interoceptive stimuli, sex differences",
author = "Bevins, {Rick A} and Sergios Charntikov",
year = "2015",
month = "3",
day = "18",
doi = "10.1021/acschemneuro.5b00018",
language = "English (US)",
volume = "6",
pages = "359--361",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "3",

}

TY - JOUR

T1 - We know very little about the subjective effects of drugs in females

AU - Bevins, Rick A

AU - Charntikov, Sergios

PY - 2015/3/18

Y1 - 2015/3/18

N2 - Pharmaceutical companies assessing the nervous system effects of candidate therapeutics often use a behavioral assay in rodents that assesses the drugs subjective (internal stimulus) effects. Variants of this so-called "drug discrimination task" have also been widely used by basic scientist for more than 50 years to study the receptor actions of a host of ligands related to disease states and neuropathologies. Notably, most published research with this task has used male rats or mice. This situation is unfortunate and severely limits the utility of the research, given the well-documented differences between women and men on drug efficacy and safety, as well as known sex differences in the neural and behavioral effects of drugs. In this Viewpoint, we highlight the need for basic researchers, as well as pharmaceutical scientists, to include females in drug discrimination studies in a manner that allows detection and interpretation of potential sex differences.

AB - Pharmaceutical companies assessing the nervous system effects of candidate therapeutics often use a behavioral assay in rodents that assesses the drugs subjective (internal stimulus) effects. Variants of this so-called "drug discrimination task" have also been widely used by basic scientist for more than 50 years to study the receptor actions of a host of ligands related to disease states and neuropathologies. Notably, most published research with this task has used male rats or mice. This situation is unfortunate and severely limits the utility of the research, given the well-documented differences between women and men on drug efficacy and safety, as well as known sex differences in the neural and behavioral effects of drugs. In this Viewpoint, we highlight the need for basic researchers, as well as pharmaceutical scientists, to include females in drug discrimination studies in a manner that allows detection and interpretation of potential sex differences.

KW - Drug discrimination

KW - gender differences

KW - interoceptive stimuli

KW - sex differences

UR - http://www.scopus.com/inward/record.url?scp=84925161551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925161551&partnerID=8YFLogxK

U2 - 10.1021/acschemneuro.5b00018

DO - 10.1021/acschemneuro.5b00018

M3 - Article

C2 - 25627010

AN - SCOPUS:84925161551

VL - 6

SP - 359

EP - 361

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 3

ER -